The host microbiota is associated with the occurrence and development of esophageal squamous cell carcinoma

Jing Zuo; Yanjun Liu; Wenjing Lv; Yudong Wang; Zhisong Fan; Long Wang; Li Feng; Xue Zhang; Jing Han; Zhiyu Ni

doi:10.1093/procel/pwac024

PDF(726 KB)

Protein Cell ›› 2023, Vol. 14 ›› Issue (4) : 294-298. DOI: 10.1093/procel/pwac024

LETTER

The host microbiota is associated with the occurrence and development of esophageal squamous cell carcinoma

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Jing Zuo, Yanjun Liu, Wenjing Lv, Yudong Wang, Zhisong Fan, Long Wang, Li Feng, Xue Zhang, Jing Han, Zhiyu Ni. The host microbiota is associated with the occurrence and development of esophageal squamous cell carcinoma. Protein Cell, 2023, 14(4): 294‒298 https://doi.org/10.1093/procel/pwac024

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011;140:1720–1728. CrossRef Google scholar

[2]	Chen X, Winckler B, Lu M, et al. Oral microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China. PLoS One 2015;10:e0143603. CrossRef Google scholar

[3]	Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635–1638. CrossRef Google scholar

[4]	He Y, Wu W, Wu S, et al. Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis. Microbiome 2018;6:172. CrossRef Google scholar

[5]	Li J, Zhao F, Wang Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 2017;5:14. CrossRef Google scholar

[6]	Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut 2016;65:330–339. CrossRef Google scholar

[7]	Marchesi JR, Dutilh BE, Hall N, et al. Towards the human colorectal cancer microbiome. PLoS One 2011;6:e20447. CrossRef Google scholar

[8]	May M, Abrams JA. Emerging insights into the esophageal microbiome. Curr Treat Options Gastroenterol 2018;16:72–85. CrossRef Google scholar

[9]	Poore GD, Kopylova E, Zhu Q, et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 2020;579:567–574. CrossRef Google scholar

[10]	Shao D, Vogtmann E, Liu A, et al. Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China. Cancer 2019;125:3993–4002. CrossRef Google scholar

[11]	Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin 2021;71:209–249. CrossRef Google scholar

[12]	Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013;342:971–976. CrossRef Google scholar

[13]	Wang J, Kurilshikov A, Radjabzadeh D, et al. Meta-analysis of human genome-microbiome association studies: the MiBioGen consortium initiative. Microbiome 2018;6:101. CrossRef Google scholar

[14]	Yamamura K, Baba Y, Nakagawa S, et al. Human Microbiome fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res 2016;22:5574–5581. CrossRef Google scholar

[15]	Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222–227. CrossRef Google scholar